There is no human experience of acute overdosage with remdesivir. Treatment of overdose with remdesivir should consist of general supportive measures including monitoring of vital signs and observation of the clinical status of the patient. There is no specific antidote for overdose with remdesivir.
Please confirm if you are a healthcare professional.
Disclaimer: Mylan, a Viatris company does not recommend the use of its product Desrem™ (Remdesivir for injection 100mg/vial, hereinafter, the “Product”) in any manner inconsistent with that described in the full prescribing information. The data contained in this microsite is for medical and scientific informational purposes only. Information presented on the microsite should not be construed as advice or recommendation for using the Product. Mylan, a Viatris company expressly disclaims liability for any undue consequences arising out of off-label use of the Product. Mylan, a Viatris company or any of its affiliates, directors, employees, officers, consultants, service providers shall not be responsible in any manner whatsoever, for any action taken, opinions expressed, advice rendered or accepted, any direct, incidental, special or consequential loss and damage caused on the basis of any material or information presented on this microsite. Please refer to full prescribing information before prescribing the Product.
